US Stock MarketDetailed Quotes

JANX Janux Therapeutics

Watchlist

66.835
+6.975+11.65%

Close Dec 4 16:00 ET

66.803
-0.033-0.05%

Post 20:01 ET

3.51BMarket Cap-57123P/E (TTM)

Janux Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Janux Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 1.211M	--
--	2024/Q4	-- / 490.000K	--
--	2024/Q3	439.000K / 1.645M	--
--	2024/Q2	8.897M / 863.120K	--
--	2024/Q1	1.252M / 1.018M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 1.211M--

--2024/Q4-- / 490.000K--

--2024/Q3439.000K / 1.645M--

--2024/Q28.897M / 863.120K--

--2024/Q11.252M / 1.018M--

Unlock Free Earnings Estimates

Open Account

Janux Therapeutics Earnings Reports

Janux Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 6 16:29 ET

Janux Therapeutics | 8-K: Janux Therapeutics Reports Third Quarter 2024 Financial Results and Business Highlights

Nov 6 16:15 ET

Janux Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 7 22:24 ET

Janux Therapeutics | 8-K: Janux Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights

Aug 7 16:28 ET

Analyst Rating

Updated: Dec 4, 2024

Strong Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall